PARIS, March 23 (Reuters) – Sanofi SASY.PA announced on Wednesday that it would stop all new expenditure unrelated to the supply of its essential medicines and vaccines in Russia and Belarus.
“In full alignment with the position of the international community, we have taken the decision with immediate effect to stop any new expenditure that would not be directly linked to the supply of our essential medicines and vaccines in Russia and Belarus”, said the French laboratory in a statement posted on Twitter.
(Written by Matthieu Protard and Jean Terzian, edited by Jean-Michel Bélot)